The Smartest Investors Club
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Smartest Investors Club

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
House vote imminent on Trump-backed bill to avoid government shutdown
next post
Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

You may also like

Lithium and Niobium Anomalies Defined at Mt Gordon

Quimbaya Gold Appoints Ricardo Sierra as Vice-President of...

Copper Price Forecast: Top Trends for Copper in...

Nevada Organic Phosphate Announces Murdock Mountain Environmental Assessment...

West High Yield (W.H.Y.) Resources Ltd. Announces Amended...

Top 5 Canadian Mining Stocks This Week: Durango...

Mark Skousen: This is the Only Way Gold...

12 Generative AI Stocks to Watch as ChatGPT...

ION Energy Acquires New Canadian Exploration Asset

Bold Ventures Provides Year End Project Overview

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends US Miners Soaring

    • China snubs Asia’s largest defense forum as tensions with US simmer

    • Teen’s death sparks calls to ban viral head-on tackle game inspired by American football’s biggest hits

    • Cardiex Completes Placement & Launches Entitlement Offer

    • CDX May Investor Presentation

    Categories

    • Business (1,671)
    • Investing (4,988)
    • Politics (7,825)
    • World (6,333)
    • Terms & Conditions
    • Privacy Policy
    • About us

    Disclaimer: thesmartestinvestorsclub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 thesmartestinvestorsclub.com | All Rights Reserved


    Back To Top